Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    November 2017
  1. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    >> Share

    October 2017
  2. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    >> Share

  3. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    >> Share

    September 2017
  4. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    >> Share

    August 2017
  5. YI Y, Huang C, Zhang Y, Tian S, et al
    Exploring a common mechanism of alcohol-induced deregulation of RNA Pol III genes in liver and breast cells.
    Gene. 2017;626:309-318.
    >> Share

    July 2017
  6. BELYAVSKAYA VA, Prudnikova TY, Domanitskaya NV, Litviakov NV, et al
    GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
    Gene. 2017 Jul 19. pii: S0378-1119(17)30578-4. doi: 10.1016/j.gene.2017.
    >> Share

    June 2017
  7. ZHOU J, Hang D, Jiang Y, Chen J, et al
    Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30503-6. doi: 10.1016/j.gene.2017.
    >> Share

  8. YELKEN BO, Balci T, Susluer SY, Kayabasi C, et al
    The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30505-X. doi: 10.1016/j.gene.2017.
    >> Share

    April 2017
  9. YANG SJ, Wang DD, Li J, Xu HZ, et al
    Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
    Gene. 2017 Apr 21. pii: S0378-1119(17)30283-4. doi: 10.1016/j.gene.2017.
    >> Share

  10. SHUI Y, Yu X, Duan R, Bao Q, et al
    miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.
    Gene. 2017;609:80-87.
    >> Share

  11. ZHOU S, Li J, Xu H, Zhang S, et al
    Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Gene. 2017 Apr 18. pii: S0378-1119(17)30277-9. doi: 10.1016/j.gene.2017.
    >> Share

  12. SULTANA R, Kataki AC, Borthakur BB, Basumatary TK, et al
    Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Gene. 2017 Apr 14. pii: S0378-1119(17)30272-X. doi: 10.1016/j.gene.2017.
    >> Share

  13. HUANG H, Li C, Ren G
    Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
    Gene. 2017 Apr 12. pii: S0378-1119(17)30246-9. doi: 10.1016/j.gene.2017.
    >> Share

    March 2017
  14. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Corrigendum to "Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer" [Gene 608C (2017) 73-78].
    Gene. 2017 Mar 28. pii: S0378-1119(17)30210-X. doi: 10.1016/j.gene.2017.
    >> Share

  15. ZHANG K, Wang YW, Wang YY, Song Y, et al
    Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Gene. 2017 Mar 27. pii: S0378-1119(17)30218-4. doi: 10.1016/j.gene.2017.
    >> Share

  16. MANJEGOWDA MC, Gupta PS, Limaye AM
    Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Gene. 2017 Mar 7. pii: S0378-1119(17)30141-5. doi: 10.1016/j.gene.2017.
    >> Share

    February 2017
  17. MAURO JA, Yavorski JM, Blanck G
    Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes.
    Gene. 2017 Feb 28. pii: S0378-1119(17)30126-9. doi: 10.1016/j.gene.2017.
    >> Share

  18. DEHGHAN Z, Sadeghi S, Tabatabaeian H, Ghaedi K, et al
    ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
    Gene. 2017 Feb 16. pii: S0378-1119(17)30105-1. doi: 10.1016/j.gene.2017.
    >> Share

    January 2017
  19. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
    Gene. 2017 Jan 18. pii: S0378-1119(17)30032-X. doi: 10.1016/j.gene.2017.
    >> Share

    December 2016
  20. EL HADI H, Abdellaoui-Maane I, Kottwitz D, El Amrani M, et al
    Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    Gene. 2016 Dec 28. pii: S0378-1119(16)31027-7. doi: 10.1016/j.gene.2016.
    >> Share

  21. PRONINA IV, Loginov VI, Burdennyy AM, Fridman MV, et al
    DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Gene. 2016 Dec 17. pii: S0378-1119(16)31007-1. doi: 10.1016/j.gene.2016.
    >> Share

  22. LI HC, Chen YF, Feng W, Cai H, et al
    Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
    Gene. 2016 Dec 1. pii: S0378-1119(16)30952-0. doi: 10.1016/j.gene.2016.
    >> Share

    November 2016
  23. YANG F, Luo LJ, Zhang L, Wang DD, et al
    MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
    Gene. 2016 Nov 29. pii: S0378-1119(16)30946-5. doi: 10.1016/j.gene.2016.
    >> Share

    October 2016
  24. SHEN H, Wang D, Li L, Yang S, et al
    MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Gene. 2016 Oct 13. pii: S0378-1119(16)30820-4. doi: 10.1016/j.gene.2016.
    >> Share

  25. CHEN X, Lu P, Wang DD, Yang SJ, et al
    The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.
    Gene. 2016 Oct 13. pii: S0378-1119(16)30818-6. doi: 10.1016/j.gene.2016.
    >> Share

  26. ZHANG Q, Liang Z, Gao Y, Teng M, et al
    Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies.
    Gene. 2016 Oct 6. pii: S0378-1119(16)30799-5. doi: 10.1016/j.gene.2016.
    >> Share

    September 2016
  27. SUN Z, Wu Z, Zhang F, Guo Q, et al
    PRAME is critical for breast cancer growth and metastasis.
    Gene. 2016 Sep 12. pii: S0378-1119(16)30732-6. doi: 10.1016/j.gene.2016.
    >> Share

  28. LUO LJ, Yang F, Ding JJ, Yan DL, et al
    MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Gene. 2016 Sep 1. pii: S0378-1119(16)30702-8. doi: 10.1016/j.gene.2016.
    >> Share

    August 2016
  29. SHEN H, Li L, Yang S, Wang D, et al
    MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3beta signaling pathway.
    Gene. 2016 Aug 11. pii: S0378-1119(16)30633-3. doi: 10.1016/j.gene.2016.
    >> Share

  30. HOU L, Chen M, Wang M, Cui X, et al
    Systematic analyses of key genes and pathways in the development of invasive breast cancer.
    Gene. 2016 Aug 6. pii: S0378-1119(16)30624-2. doi: 10.1016/j.gene.2016.
    >> Share

  31. JIA Z, Liu Y, Gao Q, Han Y, et al
    miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Gene. 2016 Aug 6. pii: S0378-1119(16)30631-X. doi: 10.1016/j.gene.2016.
    >> Share

    July 2016
  32. YANG F, Liu YH, Dong SY, Yao ZH, et al
    Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer.
    Gene. 2016 Jul 2. pii: S0378-1119(16)30528-5. doi: 10.1016/j.gene.2016.
    >> Share

  33. SAREDDY GR, Vadlamudi RK
    PELP1: Structure, biological function and clinical significance.
    Gene. 2016;585:128-34.
    >> Share

    June 2016
  34. YERMACHENKO A, VolodymyrDvornyk
    UGT2B4 previously implicated in the risk of breast cancer is associated with menarche timing in ukrainian females.
    Gene. 2016 Jun 6. pii: S0378-1119(16)30479-6. doi: 10.1016/j.gene.2016.
    >> Share

  35. WANG DD, Li J, Sha HH, Chen X, et al
    miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27 expression.
    Gene. 2016 Jun 6. pii: S0378-1119(16)30477-2. doi: 10.1016/j.gene.2016.
    >> Share

    May 2016
  36. SEVINC ED, Cecener G, Ak S, Tunca B, et al
    Expression and Clinical Significance of miRNAs That May Be Associated with the FHIT Gene in Breast Cancer.
    Gene. 2016 May 25. pii: S0378-1119(16)30410-3. doi: 10.1016/j.gene.2016.
    >> Share

  37. DEB P, Bhan A, Hussain I, Ansari KI, et al
    Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo.
    Gene. 2016 May 12. pii: S0378-1119(16)30367-5. doi: 10.1016/j.gene.2016.
    >> Share

  38. KARA M, Kaplan M, Bozgeyik I, Ozcan O, et al
    Mtus1 Tumor Suppressor And Its Mirna Regulators In Fibroadenoma And Breast Cancer.
    Gene. 2016 May 4. pii: S0378-1119(16)30363-8. doi: 10.1016/j.gene.2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016